Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Breakthrough treatments for cancer patients are presented at ASCO
Clinicians and scientist from The Royal Marsden and the ICR will be presenting new pioneering research at the American Society of Clinical Oncology Annual Meeting.
Gene link to higher rates of bowel cancer in men
Scientists have shown for the first time that one of the sex chromosomes is involved in the development of a cancer that can afflict both genders, according to a study in Nature Genetics.
New test may reduce chemotherapy use in breast cancer
A new test called IHC4 that is being considered for use on the NHS could identify patients at such low risk of their breast cancer returning after surgery that they may be spared chemotherapy.
Drug developers welcome NICE guidance on abiraterone
The Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation Trust have welcomed the publication of guidance from the National Institute for Health and Clinical Excellence (NICE) recommending that patients with advanced prostate cancer receive abiraterone acetate on the NHS
New understanding of breast cancer genes and mutations
Researchers have identified nine new genes that drive the development of breast cancer, taking the tally associated with this type of cancer to 40. The study, which involved ICR scientists, published in the journal Nature.
Leading prostate cancer researchers elected to Academy of Medical Sciences
Two eminent researchers from the ICR and The Royal Marsden have been elected to the Academy of Medical Sciences in recognition of their efforts to defeat prostate cancer.
Next-generation “epigenetic” cancer pill shown to be safe
Scientists have shown that a brand new type of cancer pill that exploits the emerging field of epigenetics is safe for human use, according to a Phase I trial reported today in Clinical Cancer Research.
Combining prostate cancer drugs could delay drug resistance, study finds
Combing two new prostate cancer drugs could increase the number of men who respond to treatment and the length of time they benefit, research led by the ICR has shown.
Scientists find DNA variants linked with childhood kidney cancer
An international collaboration led by The Institute of Cancer Research (ICR) has found variations of the genetic code in two regions of the genome that increase the risk of developing Wilms tumour.
Existing drugs could treat smokers’ lung cancer
A common cancer drug and a drug used for a rare condition affecting the heart could together treat an aggressive form of lung cancer called non-small cell lung cancer (NSCLC).
Protein ‘block’ kills childhood cancer cells
An experimental drug that blocks an essential cell protein could be used to treat Wilms tumour, a childhood cancer that affects the kidneys.
Men with “breast cancer gene” four times more likely to get prostate cancer
Men with a faulty gene known to increase the risk of breast cancer in women are four times more likely to develop prostate cancer, important new research published in the British Journal of Cancer today shows.